New therapeutic strategy for gastric carcinoma: A two-step evaluation of malignant potential from its molecular biologic and pathologic characteristics

Journal of Surgical Oncology

Volumn 72, Issue 3, 1999, Pages 142-149

  Kuwahara, Atsuo ^a   Katano, Mitsuo ^b   Nakamura, Mitsunari ^a   Fujimoto, Kazuma ^a   Miyazaki, Kohji ^a   Mori, Mitsuru ^a   Morisaki, Takashi ^b  

^a SAGA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Biopsy specimen; Nodal involvement; Platelet derived growth factor A (PDGF A) mRNA expression; Transforming growth factor 1 (TGF 1) mRNA expression

Indexed keywords

MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR A; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA;

HUMANS; LYMPHATIC METASTASIS; PLATELET-DERIVED GROWTH FACTOR; RNA, MESSENGER; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032756917     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199911)72:3<142::AID-JSO6>3.0.CO;2-B     Document Type: Article

References (37)

1. Kim JP, Yang HK, Oh, ST: Is the new UICC staging system of gastric cancer reasonable? Comparison of 5-year survival rate of gastric cancer by old and new UICC stage classification. Surg Oncol 1992;1:209-213.
2. Moriguchi S, Hayashi Y, Nose Y, et al.: A comparison of the logistic regression and the Cox proportional hazard models in retrospective studies on the prognosis of patients with gastric cancer. J Surg Oncol 1993;52:9-13.
3. Marubini E, Bonfanti G, Bozzetti F, et al.: A prognostic score for patients resected for gastric cancer. Eur J Cancer 1993;29A:845-850.
4. Shiozawa N, Kodama M, Chida T, et al.: Recurrent death among early gastric cancer patients: 20-years' experience. Hepatogastroenterology 1994;41:244-247.
5. Kim JP, Kim YW, Yang HK, Noh DY: Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J Surg 1994;18:872-877.
6. Kim JP, Hur YS, Yang HK: Lymph node metastasis as a significant prognostic factor in early gastric cancer: analysis of 1,136 early gastric cancers. Ann Surg Oncol 1995;2:308-313.
7. Noguchi M, Miyazaki I: Prognostic significance and surgical management of lymph node metastasis in gastric cancer. A review. Br J Surg 1996;83:156-161.
8. Korenaga D, Okuyama T, Orita H,et al.: Role of intraoperative assessment of lymph node metastasis and serosal invasion in patients with gastric cancer. J Surg Oncol 1994;55:250-254.
9. Nakamura M, Katano M, Fujimoto K, Morisaki T: A new prognostic strategy for gastric carcinoma: mRNA expression of tumour growth-related factors in endoscopic biopsy specimens. Ann Surg 1997;226:35-42.
10. Katano M, Nakamura M, Fujimoto K, et al.: Prognostic value of platelete-derived growth factor A (PDGF-A) in gastric carcinoma. Ann Surg 1998;227:365-371.
11. Japanese Research Society for Gastric Cancer: The general rules for gastric cancer study. Jpn J Surg 1985;11:127-139.
12. Chromcznski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem 1987;162:156-159.
13. Noguchi Y, Imada T, Matsumoto T, et al.: Radical surgery for gastric cancer: a review of the Japanese experience. Cancer 1989; 64:2053-2062.
14. Isozaki H, Okajima K, Kawashima Y, et al.: Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgery. J Surg Oncol 1993;53:247-251.
15. Miwa K: Evaluation of TNM classification of stomach cancer and proposal for its rational stage-grouping. Jpn J Clin Oncol 1984; 14:385-410.
16. Maehara Y, Okuyama T, Oshiro T, et al.: Early carcinoma of the stomach. Surg Gynecol Obstet 1993;177:593-597.
17. Maehara Y, Orita H, Okuyama T, et al.: Predictors of lymph node metastasis in early gastric cancer. Br J Surg 1992;79:245-247.
18. Nakamura K, Ueyama T, Yao T, et al.: Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy. Cancer 1992;70:1030-1037.
19. Norii A, Sakai M, Inoue K, et al.: A clinicopathological analysis of early gastric cancer: retrospective study with special reference to lymph node metastasis. Cancer Detect Prev 1994;18:437-441.
20. Yamao T, Shirao K, Ono H, et al.: Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer 1996;77: 602-606.
21. Natsugoe S, Aikou T, Shimada M, et al.: Occult lymph node metastasis in gastric cancer with submucosal invasion. Surg Today 1994;24:870-875.
22. Siewert JR, Kestlmeier R, Busch R, et al.: Benefits of D2 lymph node dissection for patients with gastric cancer and pNO and pN1 lymph node metastases. Br J Surg 1996;83:1144-1147.
23. Maehara Y, Oshiro T, Endo K,et al.: Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1996;119:397-402.
24. Adachi Y, Mori M, Maehara Y, Sugimachi K: Macroscopically node-negative but histologically node-positive gastric carcinoma. Br J Surg 1995;82:1254-1256.
25. Matsushita M, Hajiro K, Suzaki T, et al.: Histopathological assessment of lymph node metastasis in patients with gastric cancer. Hepatogastroenterology 1995;42:861-866.
26. Kim JP, Kwon OHJ, Oh ST, Yang HK: Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann Surg 1992;216:269-279.
27. Mok YJ, Koo BW, Whang CW, et al.: Cancer of the stomach: a review of two hospitals in Korea and Japan. World J Surg 1993; 17:777-782.
28. Siewert JR, Bottcher J, Roder JD, et al.: Prognostic relevance of systemic lymph node dissection in gastric carcinoma. Br J Surg 1993;80:1015-1018.
29. Bonenkamp JJ, Songun I, Hermans J, et al.: Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745-748.
30. Moriguchi S, Maehara Y, Korenaga D, et al.: Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg Oncol 1992;1:341-346.
31. Maehara Y, Tomisaki S, Oda S, et al.: Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients. Anticancer Res 1994;14:2755-2757.
32. Maehara Y, Oshiro T, Baba H, et al.: Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer. Surgery 1995;117:380-385.
33. Hattori T, Mori A, Hirata K, Ito I: Five-year survival rate of gastric cancer patients treated by gastrectomy, a high-dose of mitomycin-C and/or allogeneic bone marrow transplantation. Gann 1978;63:517-522.
34. The Gastrointestinal Tumor Study Group: A comparative clinical assessment of combination chemotherapy in the management of advanced gastric carcinoma. Cancer 1982;49:1362-1366.
35. Okumura T, Korenaga D, Baba H, et al.: Postoperative adjuvant chemotherapy inhibits early recurrence of early gastric carcinoma. Cancer Chemother Pharmacol 1989;23:319-322.
36. Suzuki T, Ochiai T, Nagata M, et al.: High-dose chemotherapy with autologous bone marrow transplantation in the treatment of advanced gastric cancer. Cancer 1993;72:2537-2542.
37. Averbach AM, Jacquet P: Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer. Br J Surg 1996;83:726-733.